TrialThe Lancet. Neurology2014

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Merit E Cudkowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.